Clinical Trial Update: Topical Use of Vancomycin in Reducing Sternal Wound Infection in Cardiac Surgery (SWI Trial) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating topical vancomycin to reduce sternal wound infection after cardiac surgery; trial terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery-related Infection
• Infection
• Sternal Wound Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: University of Alberta | Conditions: INFECTION | Phase 2 | Status: TERMINATED | Results posted: 2022-11-03